Psychotic symptoms in patients with borderline personality disorder: Prevalence and clinical management

Current Opinion in Psychiatry

Volumn 26, Issue 1, 2013, Pages 113-119

  Schroeder, Katrin ^a   Fisher, Helen L ^b   Schäfer, Ingo ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Borderline personality disorder; Hallucination; Paranoid ideation; Psychotic; Trauma

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PALLIPERIDONE; PLACEBO; QUETIAPINE; RISPERIDONE; UNCLASSIFIED DRUG; ZIPRASIDONE;

BORDERLINE STATE; COMORBIDITY; EMOTION; HALLUCINATION; HUMAN; PHENOMENOLOGY; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PSYCHOSIS; REVIEW;

ANTIPSYCHOTIC AGENTS; BORDERLINE PERSONALITY DISORDER; COMORBIDITY; HUMANS; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84870895336     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0b013e32835a2ae7     Document Type: Review

References (83)

1. Stern A. Psychoanalytic investigation of and therapy in the border line group of neuroses. Psychoanal Q 1938; 7:467-489.
2. Pope HG, Jonas JM, Hudson JI, et al. The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry 1983; 40:23-30.
3. Skodol AE, Oldham JM. Assessment and diagnosis of borderline personality disorder. Hosp Community Psychiatry 1991; 42:1021-1028.
4. Skodol AE, Gunderson JG, Pfohl B, et al. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry 2002; 51:936-950.
5. Slotema CW, Daalman K, Blom JD, et al. Auditory verbal hallucinations in patients with borderline personality disorder are similar to those in schizophrenia. Psychol Med 2012; 16:1-6.
6. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
7. American Psychiatric Association (APA). DSM-V Development: T 00 Borderline Personality Disorder. http://www.dsm5.org/ProposedRevision/Pages/ proposedrevision.aspx?rid=17. [Accessed 13 August 2012]
8. Zanarini MC, Gunderson JG, Frankenburg FR. Cognitive features of borderline personality disorder. Am J Psychiatry 1990; 147:57-63.
9. El-Mallakh RS, Walker KL. Hallucinations, psuedohallucinations, and parahallucinations. Psychiatry 2010; 73:34-42.
10. Hagen FW. On the theory of hallucinations (in German). Allgemeine Zeitschrift fur Psychiatrie 1868; 25:1-107.
11. van der Zwaard R, Polak MA. Pseudohallucinations: a pseudoconcept? A review of the validity of the concept, related to associate symptomatology. Compr Psychiatry 2001; 42:42-50.
12. Kingdon DG, Ashcroft K, Bhandari B, et al. Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood trauma. J Nerv Ment Dis 2010; 198:399-403.
13. Laroi F, Sommer IE, Blom JD, et al. The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions. Schizophr Bull 2012; 38:724-733.
14. Daalman K, Boks MP, Diederen KM, et al. The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. J Clin Psychiatry 2011; 72:320-325.
15. Copolov D, Trauer T, Mackinnon A. On the nonsignificance of internal versus external auditory hallucinations. Schizophr Res 2004; 69:1-6.
16. Dorahy MJ, Shannon C, Seagar L, et al. Auditory hallucinations in dissociative identity disorder and schizophrenia with and without a childhood trauma history: similarities and differences. J Nerv Ment Dis 2009; 197:892-898.
17. Brewin CR, Patel T. Auditory pseudohallucinations in United Kingdom war veterans and civilians with posttraumatic stress disorder. J Clin Psychiatry 2010; 71:419-425.
18. Daalman K, Diederen KM, Derks EM, et al. Childhood trauma and auditory verbal hallucinations. Psychol Med 2012; 16:1-10.
19. Diederen KM, Daalman K, de Weijer AD, et al. Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophr Bull 2012; 38:1074-1082.
20. Adams B, Sanders T. Experiences of psychosis in borderline personality disorder: a qualitative analysis. J Ment Health 2011; 20:381-391.
21. Chopra HD, Beatson JA. Psychotic symptoms in borderline personality disorder. Am J Psychiatry 1986; 143:1605-1607.
22. George A, Soloff PH. Schizotypal symptoms in patients with borderline personality disorders. Am J Psychiatry 1986; 143:212-215.
23. Yee L, Korner AJ, McSwiggan S, et al. Persistent hallucinosis in borderline personality disorder. Compr Psychiatry 2005; 46:147-154.
24. Miller FT, Abrams T, Dulit R, Fyer M. Psychotic symptoms in patients with borderline personality disorder and concurrent axis I disorder. Hosp Community Psychiatry 1993; 44:59-61.
25. Nishizono-Maher A, Ikuta N, Ogiso Y, et al. Psychotic symptoms in depression and borderline personality disorder. J Affect Disord 1993; 28:279-285.
26. Suzuki H, Tsukamoto C, Nakano Y, et al. Delusions and hallucinations in patients with borderline personality disorder. Psychiatry Clin Neurosci 1998; 52:605-610.
27. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull 1973; 9:13-28.
28. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med 1999; 29:879-889.
29. Coid J, Yang M, Bebbington P, et al. Borderline personality disorder: health service use and social functioning among a national household population. Psychol Med 2009; 39:1721-1731.
30. Gunderson JG, Kolb JE, Austin V. The diagnostic interview for borderline patients. Am J Psychiatry 1981; 138:896-903.
31. Zanarini MC, Gunderson JG, Frankenburg FR, Chauncey DL. The revised diagnostic interview for borderlines: discriminating BPD from other Axis II disorders. J Pers Disord 1989; 3:10-18.
32. Sbrana A, Dell'Osso L, Benvenuti A, et al. The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum. Schizophr Res 2005; 75:375-387.
33. First MB, Gibbon M. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II). In: Hilsenroth MJ, Segal DL, editors. Comprehensive handbook of psychological assessment, Personality assessment. Vol. 2. Hoboken, NJ: John Wiley & Sons Inc.; 2004. pp. 134-143.
34. Benvenuti A, Rucci P, Ravani L, et al. Psychotic features in borderline patients: is there a connection to mood dysregulation? Bipolar Disord 2005; 7:338-343.
35. Zanarini MC, Frankenburg FR, Hennen J, et al. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry 2004; 161:2108-2114.
36. Bahorik AL, Eack SM. Examining the course and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder. Schizophr Res 2010; 124:29-35.
37. Schroeder K, Hoppe A, Andresen B, et al. Considering DSM-5: personality diagnostics in patients with schizophrenia spectrum disorders. Psychiatry 2012; 75:120-134.
38. Moran P, Walsh E, Tyrer P, et al. Does co-morbid personality disorder increase the risk of suicidal behaviour in psychosis? Acta Psychiatr Scand 2003; 107:441-448.
39. Schulz SC, Zanarini MC, Bateman A, et al. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised doubleblind placebo-controlled study. Br J Psychiatry 2008; 193:485-492.
40. Nickel MK. Aripiprazole treatment of patients with borderline personality disorder. J Clin Psychiatry 2007; 68:1815-1816.
41. Schafer I, Fisher HL. Childhood trauma and posttraumatic stress disorder in patients with psychosis: clinical challenges and emerging treatments. Curr Opin Psychiatry 2011; 24:514-518.
42. Kessler RC. The National Comorbidity Survey of the United States. Int Rev Psychiatry 1994; 6:365-376.
43. Shevlin M, Murphy J, Read J, et al. Childhood adversity and hallucinations: a community-based study using the National Comorbidity Survey Replication. Soc Psychiatry Psychiatr Epidemiol 2011; 46:1203-1210.
44. Zanarini MC. Childhood experiences associated with the development of borderline personality disorder. Psychiatr Clin North Am 2000; 23:89-101.
45. Teicher MH, Samson JA, Polcari A, McGreenery CE. Sticks, stones, and hurtful words: relative effects of various forms of childhood maltreatment. Am J Psychiatry 2006; 163:993-1000.
46. Laporte L, Paris J, Guttman H, Russell J. Psychopathology, childhood trauma, and personality traits in patients with borderline personality disorder and their sisters. J Pers Disord 2011; 25:448-462.
47. Sack M, Sachsse U, Overkamp B, Dulz B. Trauma-related disorders in patients with borderline personality disorders: Results of a multicenter study (in German). Nervenarzt 2012. [Epub ahead of print]
48. Shearer SL, Peters CP, Quaytman MS, Ogden RL. Frequency and correlates of childhood sexual and physical abuse histories in adult female borderline inpatients. Am J Psychiatry 1990; 147:214-216.
49. Zanarini MC, Williams AA, Lewis RE, et al. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry 1997; 154:1101-1106.
50. Glaser JP, Van Os J, Thewissen V, Myin-Germeys I. Psychotic reactivity in borderline personality disorder. Acta Psychiatr Scand 2010; 121:125-134.
51. Braakman MH, Kortmann FA, van den Brink W. Validity of 'posttraumatic stress disorder with secondary psychotic features': a review of the evidence. Acta Psychiatr Scand 2009; 119:15-24.
52. Shevlin M, Armour C, Murphy J, et al. Evidence for a psychotic posttraumatic stress disorder subtype based on the National Comorbidity Survey. Soc Psychiatry Psychiatr Epidemiol 2011; 46:1069-1078.
53. Mueser KT, Rosenberg SD, Goodman LA, Trumbetta SL. Trauma, PTSD, and the course of severe mental illness: an interactive model. Schizophr Res 2002; 53:123-143.
54. Zanarini MC, Frankenburg FR, Parachini EA. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder. J Clin Psychiatry 2004; 65:903-907.
55. Bogenschutz MP, George Nurnberg H. Olanzapine versus placebo in the treatment of borderline personality disorder. J Clin Psychiatry 2004; 65:104-109.
56. Linehan MM, McDavid JD, Brown MZ, et al. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2008; 69:999-1005.
57. Shafti SS, Shahveisi B. Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial. J Clin Psychopharmacol 2010; 30:44-47.
58. Soler J, Pascual JC, Campins J, et al. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder. Am J Psychiatry 2005; 162:1221-1224.
59. Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993; 34:402-405.
60. Parker GF. Clozapine and borderline personality disorder. Psychiatr Serv 2002; 53:348-349.
61. Benedetti F, Sforzini L, Colombo C, et al. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998; 59:103-107.
62. Schulz SC, Camlin KL, Berry SA, Jesberger JA. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry 1999; 46:1429-1435.
63. Zanarini MC, Schulz SC, Detke H, et al. Open-label treatment with olanzapine for patients with borderline personality disorder. J Clin Psychopharmacol 2012; 32:398-402.
64. Gruettert T, Friege L. Quetiapine in patients with borderline personality disorder and psychosis: a case series. Int J Psychiatry Clin Pract 2005; 9:180-186.
65. Mauri MC, Volonteri LS, Fiorentini A, et al. Two weeks' quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder: a naturalistic study with drug plasma levels. Expert Opin Pharmacother 2007; 8:2207-2213.
66. Friedel RO, Jackson WT, Huston CS, et al. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study. J Clin Psychopharmacol 2008; 28:345-347.
67. Bellino S, Bozzatello P, Rinaldi C, Bogetto F. Paliperidone ER in the treatment of borderline personality disorder: a pilot study of efficacy and tolerability. Depress Res Treat 2011. [Epub ahead of print]
68. Nickel MK, Loew TH, Pedrosa Gil F. Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. Psychopharmacology (Berl) 2007; 191:1023-1026.
69. Bellino S, Paradiso E, Bogetto F. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder. Psychiatry Res 2008; 161:206-212.
70. Zanarini MC, Frankenburg FR. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001; 62:849-854.
71. Zanarini MC, Schulz SC, Detke HC, et al. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2011; 72:1353-1362.
72. Zanarini MC, Vujanovic AA, Parachini EA, et al. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord 2003; 17:233-242.
73. Nickel MK, Muehlbacher M, Nickel C, et al. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2006; 163:833-838.
74. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13:595-605.
75. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962; 10:799-812.
76. Pascual JC, Soler J, Puigdemont D, et al. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. J Clin Psychiatry 2008; 69:603-608.
77. Soloff P. Special feature: psychobiologic perspectives on treatment of personality disorders. J Pers Disord 1997; 11:336-344.
78. Laddis A. Outcome of crisis intervention for borderline personality disorder and post traumatic stress disorder: a model for modification of the mechanism of disorder in complex post traumatic syndromes. Ann Gen Psychiatry 2010; 9:1-12.
79. American Psychiatric Association (APA). Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001; 158(Suppl 10):1-52.
80. Therien P, Tranulis C, Lecomte T, Berube F-A. The experience of treatment of persons with concomitant psychotic and borderline personality disorders. Psychosis 2012; 4:63-73.
81. Gleeson JF, Chanen A, Cotton SM, et al. Treating co-occurring first-episode psychosis and borderline personality: a pilot randomized controlled trial. Early Interv Psychiatry 2012; 6:21-29.
82. Chanen AM, McCutcheon LK, Germano D, et al. The HYPE Clinic: an early intervention service for borderline personality disorder. J Psychiatr Pract 2009; 15:163-172.
83. Hepworth CR, Ashcroft K, Kingdon D. Auditory Hallucinations: A Comparison of Beliefs about Voices in Individuals with Schizophrenia and Borderline Personality Disorder. Clin Psychol Psychother 2011. [Epub ahead of print]